Regeneron Pharmaceuticals (REGN) EBITDA Margin (2009 - 2026)
Regeneron Pharmaceuticals' EBITDA Margin came in at 33.03% for Q2 2026, down 0.02 percentage points from 33.04% a year earlier but up 11.78 percentage points from the prior quarter.
Powered by 
Analysis
Regeneron Pharmaceuticals (REGN) EBITDA Margin (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Regeneron Pharmaceuticals reported EBITDA Margin of 28.14%, down 2.47 percentage points year-over-year; for FY2025, it was 28.74%, down 2.76 percentage points from FY2024.
- EBITDA Margin has declined in each of the last four years, with a five-year change of -16.13 percentage points (FY2020 to FY2025).
- Going back by year, EBITDA Margin was 31.50% in FY2024 (-2.56 pp), 34.06% in FY2023 (-7.67 pp), 41.73% in FY2022 (-15.71 pp) and 57.45% in FY2021 (+12.58 pp).
- The five-year range for quarterly EBITDA Margin is 21.25% (Q1 2026) to 55.62% (Q3 2021).
- Year-over-year, EBITDA Margin has declined for 18 consecutive quarters, with an average year-over-year change of -2.15 percentage points over the last eight quarters.
- The fastest year-over-year change in EBITDA Margin over five years came in Q3 2021 (a gain of 7.13 percentage points), and the weakest in Q2 2022 (a drop of 25.07 percentage points).
- Business Quant data shows REGN's EBITDA Margin at 21.25% (Q1 2026), 26.39% (Q4 2025) and 30.99% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 39.16% |
| 10 | Regeneron Pharmaceuticals | 81.27 Bn | 47.47 Bn | 3.71 Bn | 33.03% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.03% |
| Mar 31, 2026 | 21.25% |
| Dec 31, 2025 | 26.39% |
| Sep 30, 2025 | 30.99% |
| Jun 30, 2025 | 33.04% |
| Mar 31, 2025 | 23.73% |
| Dec 31, 2024 | 29.47% |
| Sep 30, 2024 | 34.97% |
| Jun 30, 2024 | 33.56% |
| Mar 31, 2024 | 27.52% |
| Dec 31, 2023 | 31.62% |
| Sep 30, 2023 | 36.17% |
| Jun 30, 2023 | 35.45% |
| Mar 31, 2023 | 33.09% |
| Dec 31, 2022 | 36.52% |
| Sep 30, 2022 | 44.83% |
| Jun 30, 2022 | 41.45% |
| Mar 31, 2022 | 44.95% |
| Dec 31, 2021 | 54.81% |
| Sep 30, 2021 | 55.62% |
API Access
Regeneron Pharmaceuticals EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=REGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "REGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=REGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();